Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.
Washington University School of Medicine in St. Louis and Caeli Vascular, Inc., are developing the first sequestered therapy device for removal of deep vein thrombosis.
Residents in the Department of Surgery’s residency programs answer frequently asked questions about Washington University School of Medicine, living in St. Louis and life as a resident.
The Washington University campus community is making headlines every day. Members of the School of Medicine are regularly featured in local, national and international news stories. Department of Surgery faculty, staff and medical students are leaders in their specialties, and share their expertise when called upon. Campus Catch-Up collects some of these stories and celebrates members of the community who are receiving recognition.
Business Director Emily Hixson Shepherd is growing as a leader in the Department of Surgery Innovations in medicine save lives. Surgeons at Washington University School of Medicine in St. Louis—whom we often recognize for their accomplishments in the operating room—are at the forefront of clinical, public health, and basic and translational research in their respective […]